Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Charlotte Cerquira"'
Autor:
Anna Meta Dyrvig Kristensen, Ann Bovin, Ann Dorthe Zwisler, Charlotte Cerquira, Christian Torp-Pedersen, Hans Erik Bøtker, Ida Gustafsson, Karsten Tange Veien, Kristian Korsgaard Thomsen, Michael Hecht Olsen, Mogens Lytken Larsen, Olav Wendelboe Nielsen, Per Hildebrandt, Sussie Foghmar, Svend Eggert Jensen, Theis Lange, Thomas Sehested, Tomas Jernberg, Dan Atar, Borja Ibanez, Eva Prescott
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials e
Externí odkaz:
https://doaj.org/article/b2a595e6a6e1488cb7c02796601af971
Autor:
Sussie Foghmar, Kristian Korsgaard Thomsen, Karsten Tange Veien, Tomas Jernberg, Christian Torp-Pedersen, Thomas S. G. Sehested, Eva Prescott, Per Hildebrandt, Anna Meta Dyrvig Kristensen, Borja Ibanez, Ann-Dorthe Zwisler, Ann Bovin, Hans Erik Bøtker, Theis Lange, Ida Gustafsson, Svend Eggert Jensen, Michael H. Olsen, Mogens Lytken Larsen, Charlotte Cerquira, Olav W. Nielsen, Dan Atar
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Kristensen, A M D, Bovin, A, Zwisler, A D, Cerquira, C, Torp-Pedersen, C, Bøtker, H E, Gustafsson, I, Veien, K T, Thomsen, K K, Olsen, M H, Larsen, M L, Nielsen, O W, Hildebrandt, P, Foghmar, S, Jensen, S E, Lange, T, Sehested, T, Jernberg, T, Atar, D, Ibanez, B & Prescott, E 2020, ' Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction : Study protocol for a randomized controlled trial ', Trials, vol. 21, no. 1, 415 . https://doi.org/10.1186/s13063-020-4214-6
Repisalud
Instituto de Salud Carlos III (ISCIII)
Trials
Kristensen, A M D, Bovin, A, Zwisler, A D, Cerquira, C, Torp-Pedersen, C, Bøtker, H E, Gustafsson, I, Veien, K T, Thomsen, K K, Olsen, M H, Larsen, M L, Nielsen, O W, Hildebrandt, P, Foghmar, S, Jensen, S E, Lange, T, Sehested, T, Jernberg, T, Atar, D, Ibanez, B & Prescott, E 2020, ' Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction : Study protocol for a randomized controlled trial ', Trials, vol. 21, 415 . https://doi.org/10.1186/s13063-020-4214-6
Kristensen, A M D, Bovin, A, Zwisler, A D, Cerquira, C, Torp-Pedersen, C, Bøtker, H E, Gustafsson, I, Veien, K T, Thomsen, K K, Olsen, M H, Larsen, M L, Nielsen, O W, Hildebrandt, P, Foghmar, S, Jensen, S E, Lange, T, Sehested, T, Jernberg, T, Atar, D, Ibanez, B & Prescott, E 2020, ' Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction : Study protocol for a randomized controlled trial ', Trials, vol. 21, no. 1, 415 . https://doi.org/10.1186/s13063-020-4214-6
Repisalud
Instituto de Salud Carlos III (ISCIII)
Trials
Kristensen, A M D, Bovin, A, Zwisler, A D, Cerquira, C, Torp-Pedersen, C, Bøtker, H E, Gustafsson, I, Veien, K T, Thomsen, K K, Olsen, M H, Larsen, M L, Nielsen, O W, Hildebrandt, P, Foghmar, S, Jensen, S E, Lange, T, Sehested, T, Jernberg, T, Atar, D, Ibanez, B & Prescott, E 2020, ' Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction : Study protocol for a randomized controlled trial ', Trials, vol. 21, 415 . https://doi.org/10.1186/s13063-020-4214-6
BackgroundTreatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9398f1a668d3def37b9b338c863c324
https://hdl.handle.net/20.500.12105/10356
https://hdl.handle.net/20.500.12105/10356
Publikováno v:
Circulation. 125
Background: Tanaka et al (J Hum Hypert 2002; 16: 97-103) developed a simple method to estimate populational 24-h urinary sodium excretion using a casual urine specimen. However, this method was developed and validated in a Japanese population and thu